SEC Form D · filed January 6, 2021
EyePoint Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (25)
Douglas W. Godshall · Watertown, MADirectorNancy Lurker · WATERTOWN, MAExec · DirectorRonald W. Eastman · Watertown, MADirectorGeorge O. Elston · Watertown, MAExecWendy O. Dicicco · Watertown, MADirectorJason R. Roswig · New York, NYDirectorSachin C. Bavishi · New York, NYDirectorMichael Puopolo · New York, NYExec · DirectorScott Jones · Fort Worth, TXExecDario Paggiarino, M.D · WATERTOWN, MAExecGoran Ando · Reading, United KingdomDirectorDavid R. Guyer, M.D · Watertown, MADirectorJohn R. Landis, Ph.D., M.S · Watertown, MADirectorYe R. Liu · Watertown, MADirectorHalle Capital Partners GP LLC · New York, NYDirectorKirsten Green · San Francisco, CADirectorStefan K. Schauss · VANCOUVER, British Columbia, CanadaExec · DirectorScott Jones · Houston, TXExecDario Paggiarino, M.D · WATERTOWN, MAExecGoran Ando · WATERTOWN, MADirectorGeorge O. Elston · Watertown, MAExecWendy O. Dicicco · Watertown, MADirectorDavid R. Guyer, M.D · Watertown, MADirectorJohn R. Landis, Ph.D., M.S · Watertown, MADirectorYe R. Liu · Watertown, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗